2019 Vaccines Process Development & Commercialization Workshop

2019 Vaccines Bioprocess Development

June 11-13, 2019 • MIT, Cambridge, MA

The UCL MBI Industrial Training Programme in collaboration with Massachusetts Institute of Technology is announcing its 2019 Vaccines Bioprocess Development & Commercialization Workshop.

This three-day workshop will explore the critical issues at the various stages of vaccine development. International experts with over 10 years’ experience in their field will lead delegates in developing their understanding in the research, development, operational and regulatory challenges of the vaccine market. In addition to expert lectures and excellent networking opportunities with your peers, one case study will be conducted during the workshop about manufacturing at-risk with real examples from the influenza manufacturing process.

Workshop Highlights
	June 11 Speakers Jacqueline Wolfrum, MIT Indresh Srivastava, Sanofi Barry Buckland, UCL Derek O'Hagan, GSK Adrian Hill, Oxford Dan Barouch, Harvard	June 12 Speakers Tarit Mukhopadhyay, Merck & Co John Aunins, Seres Paul Barone, MIT Steve Kolodziej, Pfizer Martin Wisher, MilliporeSigma Stefanie Frank, UCL Case Study - Flu Vaccine Matthew Downham, AstraZeneca	June 13 Keynote Speaker Mark Feinberg, IAVI Speakers J. Christopher Love, MIT David Robinson, B&MGF José Castillo, Univercells Rahul Singhvi, Takeda
June 13 Panel Discussion Responding in Time: Dealing with Predictable and Unpredictable Moderator: Stacy Springs, MIT Panel Members Include: Drusilla Burns, FDA \| Keith Chidwick, Parexel \| Kimberly Duffy, Merck \| David Robinson, B&MGF

This workshop is suitable for:

Scientists and engineers new to the vaccines sector (recent graduates / research scientists).
Scientists and technical managers who wish to broaden their knowledge in various vaccine technologies and platforms, exploring the interplay between process choices and regulation.
Project Managers, funders and policy-makers wanting to gain an understanding in vaccines.

MBI Background - 25 years ago UCL Biochemical Engineering created the award winning MBI training programme to provide a series of innovative UCL-accredited short courses in bioprocessing. These courses are designed for industry in collaboration with experts to support continued professional and technical development. Courses are designed for flexible professional and technical development with options for achieving up to Masters level qualifications.